Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.
Press releases published on July 22, 2025
Built for Pharma, Designed for Patients: smartpatient Launches New Digital Health Hub
EIN Presswire
·
July 22, 2025
New digital hub offers pharmaceutical companies an immersive experience, highlighting smartpatient’s integrated digital health ecosystem. MUNICH, GERMANY, July 22, 2025 /EINPresswire.com/ -- Smartpatient, the creator of MyTherapy, the world’s most …
Flora Strengthens Executive Leadership with Key Appointments Across Product, Data, and Technology Teams
EIN Presswire
·
July 22, 2025
Flora Management, is proud to announce 3 major leadership appointments that further cement its position as a category-defining force in HIT innovation. NEW YORK CITY, NY, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Flora Management, a leading …
Bear Paw Press Announces Inspiring New Release
EIN Presswire
·
July 22, 2025
Wonder and Joy for the Wired and Tired on sale August 12, 2025 LOUISVILLE, KY, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Bear Paw Press is thrilled to announce the publication of Wonder and Joy for the Wired and Tired: A Guide to Finding …
Biomed Industries to Present Four Studies at AAIC 2025 on Breakthrough Alzheimer’s, Rett Syndrome, and Obesity Therapies
EIN Presswire
·
July 22, 2025
Biomed Industries, Inc. to Present Four Pivotal Studies at AAIC 2025 on Breakthrough Alzheimer’s, Rett Syndrome, and Obesity Therapies SAN JOSE, CA, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Biomed Industries, Inc., a leading biopharmaceutical …
Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences
GlobeNewswire
·
July 22, 2025
VICTORIA, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to …
Dr. Speron’s Natural Skin Care, LLC Examines Popular Skincare Ingredients and Their Effectiveness
EIN Presswire
·
July 22, 2025
Dr. Speron’s Natural Skin Care, LLC Examines Popular Skincare Ingredients and Their Effectiveness CHICAGO, IL, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- With the skincare industry flooded with trendy ingredients and miracle claims, it’s easy …
G7+7 Petition Exceeding a Quarter Million Signatures Marks First Year of Calling to End Forced Organ Harvesting in China
EIN Presswire
·
July 22, 2025
Commemorating July 20, 1999, when the Chinese Communist Party Launched the Nationwide Persecution of Falun Gong Practitioners WASHINGTON, DC, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- On the anniversary of the G7+7 Petition, the international …
Glycerol Market Thriving Worldwide Growth, Trending Business Factors & Forecast to 2031
EIN Presswire
·
July 22, 2025
The global glycerol market is projected to reach $5.1 billion by 2031, growing at a CAGR of 1.7% from 2022 to 2031. WILMINGTON, DE, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- The global glycerol industry was estimated at $4.3 billion in 2021, …
Enzymes Market Share to reach $10.2 billion by 2031 | Growth With Recent Trends & Demand
EIN Presswire
·
July 22, 2025
PORTLAND, IA, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global enzymes market size is estimated to reach $10.2 billion by 2031, having endorsed a value of $5.8 billion in 2021, and …
Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025
GlobeNewswire
·
July 22, 2025
ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …
DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer
GlobeNewswire
·
July 22, 2025
Châtillon, France, July 22, 2025 DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), a clinical-stage biopharmaceutical company, today …
DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines
GlobeNewswire
·
July 22, 2025
Châtillon, France, le 22 juillet (22 :30 CEST) 2025 DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT— CUSIP: 23306J309), …
STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025
GlobeNewswire
·
July 22, 2025
DUBLIN, IRELAND, July 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 first quarter results at 9:00 a.m. ET on August 7, 2025. The conference …
Lutein and Zeaxanthin Market 2025 Trends: Expected to Grow at a CAGR of 4.9% from 2025 to 2031, Claims AMR
EIN Presswire
·
July 22, 2025
PORTLAND, ID, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Lutein, zeaxanthin, and meso-zeaxanthin are three carotenoids that are specifically concentrated in the human macula. Lutein and zeaxanthin are obtained through dietary sources, such as …
Digital Sphygmomanometer Market to reach $1,560.50 Million by 2031 | Global Strategic Business Report
EIN Presswire
·
July 22, 2025
PORTLAND, KS, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global digital sphygmomanometer market was estimated at $942.55 million in 2021 and is expected to hit $1,560.50 million by …
Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire
·
July 22, 2025
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2025 on Wednesday, August …
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
GlobeNewswire
·
July 22, 2025
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis 50 mg once-daily dose of obefazimod led to a …
Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences
GlobeNewswire
·
July 22, 2025
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 operating results after stock market trading hours on …
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025
GlobeNewswire
·
July 22, 2025
WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to …
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 22, 2025
CANTON, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …